Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Current Adoption Of Composite Indices In Evaluating Rheumatoid Arthritis Patients: An Observational Study ("NEW INDICES Study")

NCT00793403 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00793403
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00793403 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Current Adoption Of Composite Indices In Evaluating Rheumatoid Arthritis Patients: An Observational Study ("NEW INDICES Study")
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
January 31, 2008
Completion date
June 30, 2010
Enrollment
293 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis